Using a NanoAssmemblr technology, develop a broad range of nanoparticle formulations, varying in size, payload and excipient characteristics. Find new designs for difficult-to-deliver drugs and hard-to-treat targets.
Peptides and Proteins
Imaging Contrast Agents
- Ionizable lipids
- Poly-lactides (ex: PLGA)
- Block copolymers (ex: PEG-b-PLGA)
- Polysaccharides (ex: chitosan, cellulose)
Organic / Inorganic NPs
- Noble metal NPs
- Rare Earth Metals
- III-V semiconductors
Precision NanoSystems technology has enabled the development of a broad range of nanoparticle formulations, varying in size (20nm to 200nm), payload (e.g. nucleic acids, hydrophobic drugs) and excipient characteristics (e.g. charge and pH tuning). With the ability to iterate and tune particle characteristics faster than before, researchers are finding new designs and opening up possibilities for targets and drugs that previously would have been difficult or taken too long to develop.
In addition to the above, other particle types have also been developed on the NanoAssemblr platform.
|Particle Type||Composition||Related Resources|
|Niosomes||Non-ionic surfactant-based Vesicle||View Paper|
|Nano-lipomer||Hybrid particles made of lipids and polymers
|Dendrimer Nanoparticle||Modular biodegradable dendrimer carrying miRNA||View Paper|